| Literature DB >> 29140695 |
Giulia Miglietta1, Susanna Cogoi1, Jessica Marinello2, Giovanni Capranico2, Alexander S Tikhomirov3, Andrey Shchekotikhin3, Luigi E Xodo1.
Abstract
The human KRAS transcript contains a G-rich 5'-UTR sequence (77% GC) harboring several G4 motifs capable to form stable RNA G-quadruplex (RG4) structures that can serve as targets for small molecules. A biotin-streptavidin pull-down assay showed that 4,11-bis(2-aminoethylamino)anthra[2,3-b]furan-5,10-dione (2a) binds to RG4s in the KRAS transcript under low-abundance cellular conditions. Dual-luciferase assays demonstrated that 2a and its analogue 4,11-bis(2-aminoethylamino)anthra[2,3-b]thiophene-5,10-dione (2b) repress translation in a dose-dependent manner. The effect of the G4-ligands on Panc-1 cancer cells has also been examined. Both 2a and 2b efficiently penetrate the cells, suppressing protein p21KRAS to <10% of the control. The KRAS down-regulation induces apoptosis together with a dramatic reduction of cell growth and colony formation. In summary, we report a strategy to suppress the KRAS oncogene in pancreatic cancer cells by means of small molecules binding to RG4s in the 5'-UTR of mRNA.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29140695 DOI: 10.1021/acs.jmedchem.7b00622
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446